Make an enquiry
Refer a patient
Patient Portal
HCP Logout

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Make an enquiry
Refer a patient

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
2024-08-27T07:31:58.024Z

FL-020-001

FL-020-001
Prostate

A First-in-human, Phase 1 Dose Escalation and Expansion Study evaluating the Safety, Tolerability and Anti-tumor Activity of [ 225Ac]Ac-FL-020, an anti-PSMA Radioconjugate (RDC), in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)

A First-in-human, Phase 1 Dose Escalation and Expansion Study evaluating the Safety, Tolerability and Anti-tumor Activity of [ 225Ac]Ac-FL-020, an anti-PSMA Radioconjugate (RDC), in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)

Trial overview

Clinical Area

Theranostics

Disease / Condition

Prostate

Study Phase

I

GenesisCare Location(s)

GenesisCare Murdoch

GenesisCare Murdoch :::
Principal Investigator(s)

Dr Joe Cardaci

 

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.